|
|
|
|
|
Session 54
Poster Presentations Viral Reservoirs and Transmission Session Day and Time: Tuesday 1:30 - 3:30 pm Room: Hall A |
Background: HIV-1 is usually detected in seminal
plasma (SP) less frequently than the corresponding blood plasma (BP) and usually
at lower levels. However, in most cohorts there are a significant minority of
men in which SP levels are equal to, or higher than BP levels. We have
identified these individuals as “seminal super
shedders” (SSS) of HIV-1 and postulate that they may represent a group of
individuals at increased risk of transmitting HIV-1.
Methods: Seventy-three (73) HIV+ men not
on therapy were enrolled. They produced matched blood and semen samples at the
same time as undergoing tests for sexually transmitted infections. Viral load
was determined by NASBA. Variables considered were; age, CDC status, CD4 count,
BPVL > 100,000 c/ml, and the presence or absence of urethritis. SSS were
defined as individuals with a SPVL/BPVL ratio > 1.
Results: Overall BPVL was significantly correlated
with SPVL, Spearman’s σ 0.53 p < 0.0001. No men had BPVL values < 400
c/ml. In contrast 22/72 (30%) had SPVL < 400 c/ml despite detectable BPVL (e.g.,
non-shedders). Men who shed virus into semen had significantly higher BPVL than
non shedders; 5.01 log10 c/ml (range 3.4–6.3) vs 4.2 log10
c/ml (3.0–5.5) p < 0.0001, Mann-Whitney U. Nine (9) men met the SSS
criteria. These men had significantly higher SPVL compared with the main
seminal shedding (SS) group; 5.6 log10 c/ml (4.1–6.5) vs 3.9 log10
c/ml (2.6–6.2) p < 0.001. In contrast, BPVL was not significantly different
between SSS and SS (4.8 log10 c/ml vs 5.02 log10 c/ml, p =
0.9). SSS were generally older; 48 yrs vs 35 yrs p < 0.02 and the presence
of urethritis was significantly over represented in the SSS group compared with
the other groups, 3/9 (33%) vs 3/63 (4.8%) of other groups (Fishers Exact test
p = 0.02). Importantly SSS was not simply explained by high BPVL as patients
(pts) with BPVL > 100,000 c/ml were equally represented in both the SSS
group 4/9 (44%) vs SS 25/63 (39%), p > 0.9. CD4 counts and CDC status were
not significantly different between the SSS and SS.
Conclusions: In HIV+1 men with detectable BPVL not on
therapy, ~30% had undetectable SPVL, ~58% had SPVL detectable at concentrations
below their BPVL. Thus ~12% of this cohort was classified as SSS. Although urethritis
accounted for 3/9 cases of SSS, studies are required to elucidate possible
reasons for the excess shedding in those pts without urethritis. This important
group of pts may pose a higher risk of transmitting HIV to their sexual
partners.